264 related articles for article (PubMed ID: 32293131)
1. Liquid Biopsy Based on Circulating Cancer-Associated Cells: Bridging the Gap from an Emerging Concept to a Mainstream Tool in Precision Medicine.
Jiménez-Zenteno AK; Cerf A
Adv Biosyst; 2020 Feb; 4(2):e1900164. PubMed ID: 32293131
[TBL] [Abstract][Full Text] [Related]
2. Circulating Tumor DNA: A Step into the Future of Cancer Management.
Fernandes Marques J; Pereira Reis J; Fernandes G; Hespanhol V; Machado JC; Costa JL
Acta Cytol; 2019; 63(6):456-465. PubMed ID: 30852572
[TBL] [Abstract][Full Text] [Related]
3. Application of liquid biopsy in precision medicine: opportunities and challenges.
Wang J; Chang S; Li G; Sun Y
Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
[TBL] [Abstract][Full Text] [Related]
4. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
Junqueira-Neto S; Batista IA; Costa JL; Melo SA
Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in breast cancer: applications in personalized medicine.
Lee JS; Magbanua MJM; Park JW
Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
[TBL] [Abstract][Full Text] [Related]
6. Liquid Biopsy: From Basic Research to Clinical Practice.
Macías M; Alegre E; Díaz-Lagares A; Patiño A; Pérez-Gracia JL; Sanmamed M; López-López R; Varo N; González A
Adv Clin Chem; 2018; 83():73-119. PubMed ID: 29304904
[TBL] [Abstract][Full Text] [Related]
7. Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine.
Bao Y; Zhang D; Guo H; Ma W
Cancer Sci; 2024 Apr; 115(4):1060-1072. PubMed ID: 38308498
[TBL] [Abstract][Full Text] [Related]
8. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
Fici P
Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
Ricciardi E; Giordani E; Ziccheddu G; Falcone I; Giacomini P; Fanciulli M; Russillo M; Cerro M; Ciliberto G; Morrone A; Guerrisi A; Valenti F
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835424
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
[TBL] [Abstract][Full Text] [Related]
11. Current and future perspectives of liquid biopsies in genomics-driven oncology.
Heitzer E; Haque IS; Roberts CES; Speicher MR
Nat Rev Genet; 2019 Feb; 20(2):71-88. PubMed ID: 30410101
[TBL] [Abstract][Full Text] [Related]
12. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
Theil G; Fornara P
Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
[TBL] [Abstract][Full Text] [Related]
13. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
Rossi G; Ignatiadis M
Cancer Res; 2019 Jun; 79(11):2798-2804. PubMed ID: 31109952
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biopsy: A New Tool in Oncology.
Costa JL; Schmitt FC
Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
[No Abstract] [Full Text] [Related]
15. Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.
Muinelo-Romay L; Casas-Arozamena C; Abal M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087246
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsy: General Concepts.
Poulet G; Massias J; Taly V
Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
[TBL] [Abstract][Full Text] [Related]
17. Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis.
De Rubis G; Rajeev Krishnan S; Bebawy M
Trends Pharmacol Sci; 2019 Mar; 40(3):172-186. PubMed ID: 30736982
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy for ovarian cancer using circulating tumor cells: Recent advances on the path to precision medicine.
Yang J; Cheng S; Zhang N; Jin Y; Wang Y
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188660. PubMed ID: 34800546
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in precision medicine: challenges and opportunities.
Rupp B; Ball H; Wuchu F; Nagrath D; Nagrath S
Trends Pharmacol Sci; 2022 May; 43(5):378-391. PubMed ID: 35272862
[TBL] [Abstract][Full Text] [Related]
20. Incorporating liquid biopsies into treatment decision-making: obstacles and possibilities.
Beije N; Martens JWM; Sleijfer S
Drug Discov Today; 2019 Sep; 24(9):1715-1719. PubMed ID: 31170504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
